| LX | TBP | ||
---|---|---|---|---|
(N = 236) | (N = 296) | |||
 | grade1–2 | grade3–4 | grade1–2 | grade3–4 |
Neutropenia | 24(10.2%) | 5(2.1%) | 87(29.4%) | 19(6.4%) |
Febrile neutropenia | 4(1.7%) | 0(0.0%) | 20(6.8%) | 4(1.4%) |
Thrombocytopenia | 12(5.1%) | 1(0.4%) | 25(8.4%) | 3(1%) |
Anemia | 4(1.7%) | 0(0.0%) | 40(13.5%) | 0(0.0%) |
Nausea/Vomiting | 60(25.4%) | 0(0.0%) | 56(18.9%) | 8(2.7%) |
Diarrhea | 92(39.0%) | 12(5.1%) | 15(5.1%) | 0(0.0%) |
Cardiac toxicity | 0(0.0%) | 0(0.0%) | 2(0.7%) | 0(0.0%) |
Rash or erythema | 45(19.1%) | 0(0.0%) | 13(4.4%) | 0(0.0%) |
ALT/AST increased | 28(11.9%) | 0(0.0%) | 32(10.8%) | 27(9.1%) |
Hand–foot syndrome | 56(23.7%) | 24(10.2%) | 7(2.4%) | 0(0.0%) |